ACTRN12621000518864进行中（未招募）未知
A multi-centre, randomised, single-blinded clinical trial comparing the effect of conservative vs. liberal oxygenation targets on survival with good neurological function in adults with suspected hypoxic ischaemic encephalopathy following a cardiac arrest who are invasively mechanical ventilated in the IC
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 1,840
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Aged greater than or equal to 18 years AND
- •2. Receiving invasive mechanical ventilation in the ICU following a cardiac arrest AND
- •3. Suspected of having hypoxic ischaemic encephalopathy (i.e. the patient has not obeyed commands following resuscitation from a cardiac arrest and there is clinical concern about possible brain damage)
排除标准
- •1. Enrolment is not considered in the patient’s best interests by the treating clinician (e.g. the patient is expected to die and is not being treated with curative intent or the treating clinician considers that one study treatment arm is either indicated or contraindicated) OR
- •2. Previously enrolled in the Mega-ROX trial OR
- •3. Greater than 12 hours have elapsed since the patient fulfilled the inclusion criteria
- •When a patient is not enrolled within 12 hours of fulfilling the eligibility criteria, he /she will be counted as eligible but missed” rather than excluded” for the purposes of describing participant flow.
研究者
相似试验
已完成
不适用
Evaluating the effects of two approaches to oxygen therapy in Intensive Care Unit patients requiring life support (mechanical ventilation)Respiratory failureCritical illnessMechanical ventilationHyperoxaemiaRespiratory - Other respiratory disorders / diseasesAnaesthesiology - Other anaesthesiologyACTRN12615000957594Medical Research Institute of New Zealand1,000
进行中（未招募）
不适用
A multi-centre, randomised, prospective, single-blinded, controlled study to investigate the efficacy and safety of a standardised maintenance dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus placebo in patients with iron deficiency caused by inflammatory bowel diseaseEUCTR2008-003591-22-LTVifor (International) Inc.200
进行中（未招募）
不适用
A multi-centre, randomised, prospective, single-blinded, controlled study to investigate the efficacy and safety of a standardised maintenance dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus placebo in patients with iron deficiency caused by inflammatory bowel diseaseIron deficiency anaemia in patients with inflammatory bowel diseaseMedDRA version: 9.1Level: LLTClassification code 10055736Term: Iron deficiency anaemia secondary to blood loss (chronic)EUCTR2008-003591-22-DKVifor (International) Inc.200
进行中（未招募）
不适用
A multi-centre, randomised, prospective, single-blinded, controlled study to investigate the efficacy and safety of a standardised maintenance dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus placebo in patients with iron deficiency caused by inflammatory bowel diseaseIron deficiency anaemia in patients with inflammatory bowel diseaseMedDRA version: 9.1Level: LLTClassification code 10055736Term: Iron deficiency anaemia secondary to blood loss (chronic)EUCTR2008-003591-22-GBVifor (International) Inc.200
进行中（未招募）
不适用
A multi-centre, randomised, prospective, single-blinded, controlled study to investigate the efficacy and safety of a standardised maintenance dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus placebo in patients with iron deficiency caused by inflammatory bowel diseaseIron deficiency anaemia in patients with inflammatory bowel diseaseMedDRA version: 9.1Level: LLTClassification code 10055736Term: Iron deficiency anaemia secondary to blood loss (chronic)EUCTR2008-003591-22-ATVifor (International) Inc.200